Kobayashi Pharmaceutical Co Ltd
TSE:4967
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Price:
5 401 JPY
-4.12%
Market Closed
Updated:
May 30, 2024
Kobayashi Pharmaceutical Co Ltd
Interest Income Expense
|
Kobayashi Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Comparables:
4911
4527
4927
4452
F
4921
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Interest Income Expense
¥1.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
16%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Interest Income Expense
¥7.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
35%
|
CAGR 10-Years
19%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Interest Income Expense
¥1.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Interest Income Expense
¥2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
|
Kao Corp
TSE:4452
|
Interest Income Expense
¥5.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
34%
|
CAGR 10-Years
9%
|
|
F
|
Fancl Corp
TSE:4921
|
Interest Income Expense
¥162m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
87%
|
CAGR 10-Years
-2%
|
See Also
What is Kobayashi Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
1.5B
JPY
1.5B
JPY
Based on the financial report for Mar 31, 2024, Kobayashi Pharmaceutical Co Ltd's Interest Income Expense amounts to 1.5B JPY.
What is Kobayashi Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
16%
16%
Over the last year, the Interest Income Expense growth was 120%. The average annual Interest Income Expense growth rates for Kobayashi Pharmaceutical Co Ltd have been 9% over the past three years , 24% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
